Latest Low-density lipoprotein Stories
WOODBRIDGE, ON, Dec. 17, 2014 /PRNewswire/ - Pivotal Therapeutics Inc.
New program will spotlight America's high cholesterol numbers TARRYTOWN, N.Y. and BRIDGEWATER, N.J., Dec. 15, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
MUTATIONS IN APOA5 GENE FOUND TO INCREASE BLOOD TRIGLYCERIDES AND HEART ATTACK RISK CAMBRIDGE, Mass., Dec.
Novel Emerging Therapies Are Expected to Reinvigorate a Market Constrained By Patent Expirations of Leading Treatments, According to Findings from Decision Resources Group BURLINGTON, Mass.,
DailyGossip.org publishes a review to the Heart Revitalized program, Andrew Dillard's new method that promises to reverse the effect of heart disease and bad cholesterol in just a few days.
All six trials met primary efficacy endpoint TARRYTOWN, N.Y. and PARIS, Nov. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- All six trials met primary efficacy endpoint - PARIS AND TARRYTOWN, N.Y., Nov. 19, 2014 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc.
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.
RESEARCHERS FIND RARE, LOSS-OF-FUNCTION MUTATIONS THAT LOWER BLOOD CHOLESTEROL AND REDUCE RISK OF HEART ATTACK CAMBRIDGE, Mass., Nov.
Thirteen Presentations Include New Analyses of PCSK9 Inhibitor at Upcoming American Heart Association Scientific Sessions THOUSAND OAKS, Calif., Nov.
- To swell, as grain or wood with water.